BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29872961)

  • 1. Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.
    Rajamanikam A; Kumar S; Samudi C; Kudva M
    Parasitol Res; 2018 Aug; 117(8):2585-2590. PubMed ID: 29872961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms.
    Vogelberg C; Stensvold CR; Monecke S; Ditzen A; Stopsack K; Heinrich-Gräfe U; Pöhlmann C
    Parasitol Int; 2010 Sep; 59(3):469-71. PubMed ID: 20363362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blastocystis: to treat or not to treat..
    Coyle CM; Varughese J; Weiss LM; Tanowitz HB
    Clin Infect Dis; 2012 Jan; 54(1):105-10. PubMed ID: 22075794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blastocystis--an enigmatic parasite].
    Stensvold CR; Arendrup MC; Nielsen HV; Mølbak K
    Ugeskr Laeger; 2009 Aug; 171(34):2388-90. PubMed ID: 19732521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.
    Raman K; Kumar S; Chye TT
    Parasitol Res; 2016 Jan; 115(1):391-6. PubMed ID: 26481491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of Blastocystis hominis, a clinical reevaluation.
    Kaya S; Cetin ES; Aridoğan BC; Arikan S; Demirci M
    Turkiye Parazitol Derg; 2007; 31(3):184-7. PubMed ID: 17918055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical profile of adult patients with Blastocystis sp. infection in Barcelona, Spain.
    Salvador F; Sulleiro E; Sánchez-Montalvá A; Alonso C; Santos J; Fuentes I; Molina I
    Parasit Vectors; 2016 Oct; 9(1):548. PubMed ID: 27741951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
    Cobuccio LG; Laurent M; Gardiol C; Wampfler R; Poppert S; Senn N; Eperon G; Genton B; Locatelli I; de Vallière S
    J Travel Med; 2023 Feb; 30(1):. PubMed ID: 36440639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.
    Dinleyici EC; Eren M; Dogan N; Reyhanioglu S; Yargic ZA; Vandenplas Y
    Parasitol Res; 2011 Mar; 108(3):541-5. PubMed ID: 20922415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence.
    Rajamanikam A; Hooi HS; Kudva M; Samudi C; Kumar S
    PLoS One; 2019; 14(2):e0212542. PubMed ID: 30794628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole.
    Moghaddam DD; Ghadirian E; Azami M
    Parasitol Res; 2005 Jun; 96(4):273-5. PubMed ID: 15915364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Blastocystis carriage with antimicrobials: reality or delusion?
    Stensvold CR; Smith HV; Nagel R; Olsen KE; Traub RJ
    J Clin Gastroenterol; 2010 Feb; 44(2):85-90. PubMed ID: 19834337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole.
    Nigro L; Larocca L; Massarelli L; Patamia I; Minniti S; Palermo F; Cacopardo B
    J Travel Med; 2003; 10(2):128-30. PubMed ID: 12650658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review.
    Batista L; Pérez Jove J; Rosinach M; Gonzalo V; Sainz E; Loras C; Forné M; Esteve M; Fernández-Bañares F
    Gastroenterol Hepatol; 2017; 40(6):381-387. PubMed ID: 28279442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy.
    Nagel R; Cuttell L; Stensvold CR; Mills PC; Bielefeldt-Ohmann H; Traub RJ
    Intern Med J; 2012 Nov; 42(11):1187-95. PubMed ID: 22032439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in Blastocystis spp. is related to subtype.
    Dhurga DB; Suresh KG; Tan TC; Chandramathi S
    Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):725-30. PubMed ID: 23141370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastocystis sp., Parasite Associated with Gastrointestinal Disorders: An Overview of its Pathogenesis, Immune Modulation and Therapeutic Strategies.
    Kumarasamy V; Anbazhagan D; Subramaniyan V; Vellasamy S
    Curr Pharm Des; 2018; 24(27):3172-3175. PubMed ID: 30084327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is paromomycin the drug of choice for eradication of Blastocystis in adults?
    van Hellemond JJ; Molhoek N; Koelewijn R; Wismans PJ; van Genderen PJ
    J Infect Chemother; 2013 Jun; 19(3):545-8. PubMed ID: 23053509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastocystis hominis: evidence for human pathogenicity and effectiveness of metronidazole therapy.
    Guirges SY; Al-Waili NS
    Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):333-5. PubMed ID: 3665198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of Blastocystis infections in Turkey.
    Ozyurt M; Kurt O; Mølbak K; Nielsen HV; Haznedaroglu T; Stensvold CR
    Parasitol Int; 2008 Sep; 57(3):300-6. PubMed ID: 18337161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.